Sickle cell disease trials in Colombia
3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Where
- Cali, Medellín, Montería
- Age
- 12 years to 100 years
- People
- 354 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06439082 - Phase 3Taking peopleA Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Where
- Antioquia, Barranquilla, Cali, Medellín, Montería, Valledupar
- Age
- 12 years and over
- People
- 510 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06612268 · EU 2023-509175-16-00 - Phase 4Taking peopleRollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
- Where
- Barranquilla, Cali, Montería, Valledupar
- Age
- 6 months to 100 years
- People
- 130 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04657822 · EU 2024-510734-41-00